Does the DTC have a policy which defines timely decision-making and communication of outcomes? Where, due to unusual or unexpected circumstances, defined timeframes are unlikely to be achieved, is this explained to the relevant stakeholders and a realistic timeframe proposed? Is there a set agenda prior to each meeting? Is there provision for proactive and responsive agenda items and a mechanism for stakeholders to submit items for consideration? GP 10: DTCs should be both proactive and responsive to issues arising and develop an annual work plan. Does the DTC develop and follow an annual work plan informed by local issues and horizon scanning, nationally and internationally? GP 11: DTCs should undertake risk assessments within the health service organisation with respect to medicines use and apply strategies to mitigate that risk. Does the DTC undertake risk assessments within the health service organisation with respect to medicines use? When are identified, are strategies identified and recommended to mitigate that risk? GP 12: DTCs should identify and prioritise a systems improvement plan and assign responsibilities and timeframes for completion. Is there a framework for the implementation and ongoing monitoring of decisions to ensure that criteria for decision-making are being consistently applied? Does the DTC identify and implement quality improvement activities when needed, assigning responsibilities and timeframes for completion? GP 13: DTCs should have in place monitoring systems to evaluate their effectiveness. Are the of reference and membership regularly reviewed to reflect organisational or functional changes? Does the DTC use a meaningful tool to evaluate their current practice and progress? Is there an assurance process to monitor its effectiveness and to enable learning to be incorporated into future process improvements?
COMMUNICATION Yes No Comment GP 14: DTCs should develop a communication strategy that ensures timely, effective and appropriate information for the intended audience. Is there a communication strategy for the timely and effective dissemination of decisions? For example, detailing method of communication, frequency, format and recipients. Is responsibility assigned for communicating decisions? Is there a communication process to ensure relevant information reaches the correct audience? GP 15: DTCs should promote the medicines management pathway by engaging with internal and external stakeholders. Does the DTC engage with and involve relevant stakeholders, e.g. local health networks and primary healthcare networks? Is continuity of medication management into consideration when making decisions? RESOURCES Yes No Comment GP 16: DTCs should be adequately resourced to undertake their functions and responsibilities. Are resources available to support audit of the DTC’s activities, in terms of internal functions and outcomes of decisions/recommendations? Does the DTC have appropriate resources to support the secretariat functions, e.g. agenda setting, documentation, follow-up of actions and minute taking? Do members have adequate time to spend on DTC activities, such as attend meetings, and review meeting papers and supporting documents? Is the DTC resourced to provide training where appropriate for its members? [Adapted with permission from: National Prescribing Centre. Supporting rational local decision-making about medicines (and treatments). A handbook of good practice guidance. Liverpool, UK: National Prescribing Centre; 2009.]